• GW4064 (SKU B1527): Reliable FXR Agonist Strategies for C...

  2026-01-21

  This article provides evidence-based guidance for biomedical researchers using GW4064 (SKU B1527), a selective non-steroidal FXR agonist, in cell viability, proliferation, and fibrosis studies. Drawing on recent peer-reviewed data and practical lab scenarios, it addresses solubility, stability, data interpretation, and vendor selection issues. Scenario-based Q&As help translate FXR pathway insights into reproducible, efficient experimental workflows.

• One-step TUNEL Cy3 Apoptosis Detection Kit: Precision Flu...

  2026-01-20

  The One-step TUNEL Cy3 Apoptosis Detection Kit offers a robust, highly specific solution for detecting apoptotic DNA fragmentation in both tissue sections and cultured cells. Utilizing terminal deoxynucleotidyl transferase (TdT) labeling and Cy3 fluorescence, this kit streamlines apoptosis research and sets a high standard for reproducibility in DNA fragmentation assays. Its validated performance ensures accurate detection of programmed cell death pathways across diverse biological contexts.

• HPF: Advanced ROS Detection for Dynamic Cell Signaling St...

  2026-01-20

  Discover how HPF (hydroxyphenyl fluorescein) empowers precise, highly reactive oxygen species detection in live-cell environments. This in-depth analysis explores HPF’s unique selectivity, its role in dissecting ROS-driven signaling pathways, and next-generation applications that go beyond conventional ROS visualization.

• SP2509: LSD1 Inhibitor for Acute Myeloid Leukemia Research

  2026-01-19

  SP2509 stands out as a next-generation LSD1 inhibitor for acute myeloid leukemia research, offering potent, selective disruption of epigenetic repression and enabling robust workflows for apoptosis and differentiation studies. Its synergy with HDAC inhibitors and proven in vivo efficacy position SP2509 as a transformative tool for cancer epigenetics and translational AML research.

454 records 31/31 page Previous First page 上5页 31